Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Boehringer Ingelheim
Chinese Patent Office
US Army

Generated: March 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019574

« Back to Dashboard

NDA 019574 describes THALITONE, which is a drug marketed by Casper Pharma Llc and Monarch Pharms and is included in two NDAs. It is available from one supplier. Additional details are available on the THALITONE profile page.

The generic ingredient in THALITONE is chlorthalidone. There are eighteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
Summary for 019574
Applicant:Casper Pharma Llc
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 019574
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for 019574
Suppliers and Packaging for NDA: 019574
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
THALITONE chlorthalidone TABLET;ORAL 019574 NDA Monarch Pharmaceuticals, Inc 61570-024 E 61570-024-01

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Dec 20, 1988TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG
Approval Date:Feb 12, 1992TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Daiichi Sankyo
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.